Literature DB >> 24740560

The mechanisms of 5-FU-PLA-O-CMC-NPS-mediated inhibition of the proliferation of colorectal cancer cell line SW480.

Jing Wu1, Le Zhang, Guo-dong Yang, Xiang-chun Lin, Rui Ji, Cang-hai Wang, Wen-jing Lou, Xiao-bo Wang.   

Abstract

We aimed to investigate how 5-FU-PLA-O-CMC-NP (5-FPOCN) inhibits the proliferation of the SW480 colon cancer cell line. Following the treatment of cell line SW480 with 0.1, 1, 10 or 100 μg/ml 5-FPOCN or 5-fluorouracil (fluorouracil, 5-Fu) for 0, 24, 48, or 72, the rate of cell was tested by the tetrazolium assay (MTT). After the SW480 cells were treated with 5-FPOCN or 5-FU for 72 h, the growth rate and apoptosis were detected. After the SW480 cells were treated with 5-FPOCN or 5-FU for 24, 48, 72, or 120, flow cytometry (FCM) was used to determine the cell cycle distribution. The changes in the expression of P21, CyclinD1 and Rb were detected by Western blotting and real-time PCR. We found that different doses of 5-FPOCN can significantly inhibit the growth rate of SW480 cells, and this effect is dose and time dependent. However, there is no significant difference from 72 to 120 h (P>0.05). After 5-FPOCN treatment for 72 h, there is a negative correlation between the concentration of 5-FPOCN and the activity of SW480 cells and a positive correlation between the concentration of 5-FPOCN and SW480 cell apoptosis. G1 phase was significantly increased, and S phase was significantly decreased in 5-FPOCN-treated SW480 cells at 72 h compared to the control group (P<0.05); there was a positive correlation between the concentration of 5-FPOCN and the above changes. It was suggested that 5-FPOCN can delay G1/S phase and that this is a dose-dependent effect. The expression of P21 protein and messenger RNA (mRNA) and Rb protein and mRNA was significantly increased in 5-FPOCN-treated SW480 cells at 72 h compared to the control group, and this was a dose- and time-dependent effect. CyclinD1 protein and mRNA expression was reduced as the dose increased, and its expression was negatively associated with the increased expression of P21. We concluded that 5-FPOCN can significantly inhibit the growth of colon cancer SW480 cells. 5-FPOCN increased P21 expression and decreased cyclin family and pRb expression to promote cell cycle delay and apoptosis.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24740560     DOI: 10.1007/s13277-014-1807-2

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  10 in total

Review 1.  Inhibition of carcinogenesis by conjugated linoleic acid: potential mechanisms of action.

Authors:  Martha A Belury
Journal:  J Nutr       Date:  2002-10       Impact factor: 4.798

2.  Epicatechin gallate induces cell death via p53 activation and stimulation of p38 and JNK in human colon cancer SW480 cells.

Authors:  Isabel Cordero-Herrera; María Angeles Martín; Laura Bravo; Luis Goya; Sonia Ramos
Journal:  Nutr Cancer       Date:  2013       Impact factor: 2.900

3.  Antioxidants enhance the cytotoxicity of chemotherapeutic agents in colorectal cancer: a p53-independent induction of p21WAF1/CIP1 via C/EBPbeta.

Authors:  R Chinery; J A Brockman; M O Peeler; Y Shyr; R D Beauchamp; R J Coffey
Journal:  Nat Med       Date:  1997-11       Impact factor: 53.440

4.  Demonstration of dose dependent cytotoxic activity in SW480 colon cancer cells by ¹⁷⁷Lu-labeled siRNA targeting IGF-1R.

Authors:  Mojtaba Fathi; Mohammad Taghikhani; Mohammad Ghannadi-Maragheh; Kamal Yavari
Journal:  Nucl Med Biol       Date:  2013-05       Impact factor: 2.408

5.  A novel pH- and time-based multi-unit potential colonic drug delivery system. I. Development.

Authors:  V K Gupta; T E Beckert; J C Price
Journal:  Int J Pharm       Date:  2001-02-01       Impact factor: 5.875

6.  [Effects and mechanisms of phosphatidylinositol 3 kinase B signal pathway on colon cancer cell SW480].

Authors:  Dong-hua Ma; Teng Long; Ya-xu Wang; Ning-bo Shu; De-li Bi
Journal:  Zhonghua Yi Xue Za Zhi       Date:  2013-02-26

7.  C-reactive protein is a negative independent factor in patients with stage IV colorectal cancer undergoing oxaliplatin-based chemotherapy.

Authors:  Minoru Fukuchi; Kohki Kuwabara; Yoshitaka Tsuji; Hiroyuki Baba; Keiichiro Ishibashi; Noriyasu Chika; Satoshi Hatano; Takeaki Matsuzawa; Kensuke Kumamoto; Youichi Kumagai; Erito Mochiki; Hideyuki Ishida
Journal:  Anticancer Res       Date:  2013-11       Impact factor: 2.480

8.  [Effect of Achyranthes bidentata polysaccharides stimulated dendritic cells co-cultured with cytokine induced killer cells against SW480 cells].

Authors:  Zhi-Dong Zhou; Da-Jing Xia
Journal:  Zhongguo Zhong Yao Za Zhi       Date:  2013-04

Review 9.  Chemotherapy with targeted agents for the treatment of metastatic colorectal cancer.

Authors:  Claus-Henning Köhne; Heinz-Josef Lenz
Journal:  Oncologist       Date:  2009-05-01

10.  New insights into the RNA-based mechanism of action of the anticancer drug 5'-fluorouracil in eukaryotic cells.

Authors:  Laura Mojardín; Javier Botet; Luis Quintales; Sergio Moreno; Margarita Salas
Journal:  PLoS One       Date:  2013-11-01       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.